S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ARTV Artiva Biotherapeutics Inc

6.53

-0.25 (-3.69%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Artiva Biotherapeutics (NASDAQ:ARTV)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Artiva Biotherapeutics Charts.

Artiva Biotherapeutics (NASDAQ:ARTV)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Artiva Biotherapeutics Charts.

Artiva Biotherapeutics Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
Monday 11 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 22 October 2024 (3 months ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 September 2024 (4 months ago) • Edgar (US Regulatory)

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
Tuesday 10 September 2024 (4 months ago) • GlobeNewswire Inc.

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Thursday 29 August 2024 (5 months ago) • GlobeNewswire Inc.

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
Thursday 18 July 2024 (6 months ago) • GlobeNewswire Inc.

More Artiva Biotherapeutics Inc News Articles

MineralRite (PK)

Good Vibrations Shoes (PK)

RespireRx Pharmaceuticals (CE)

GBT Technologies (PK)

UAV Corpoation (PK)

Saddle Ranch Media (PK)

Bioelectronics (PK)

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions